A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphomaYuankai Shi, Xin Zhang, Xiaonan Hong et al.|Journal of Hematology & Oncology|2020Cited by 50
Recombinant human endostatin in combination with CHOP regimen for peripheral T cell lymphomaQunling Zhang, Xiaonan Hong|OncoTargets and Therapy|2016Cited by 6